About 9 results found for searched term "67-42-5" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2900 | Ornidazole | Anti-infection |
| Ro 7-0207 | ||
| Ornidazole is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria. | ||
| M9325 | EGTA | Others |
| EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. | ||
| M9636 | Blebbistain | Myosin |
| BLEB; (±)-Blebbistatin | ||
| (±)-Blebbistatin (BLEB) is a small cell permeable selective myosin II inhibitor which potently relaxed normal detrusor smooth muscle. | ||
| M9842 | ML228 | HIF |
| CID-46742353; ML 228 | ||
| ML228 is a potent the HIF pathway activator, with EC50 values of 1.23 and 1.4 μM for HRE gene reporter assay and HIF-1α nuclear translocation assay respectively. | ||
| M10103 | Plecanatide | Guanylate Cyclase |
| Plecanatide is a structural analog of human uroguanylin, and similarly to uroguanylin, plecanatide functions as a guanylate cyclase-C (GC-C) agonist. | ||
| M25008 | Itepekimab | IL Receptor/Related |
| REGN-3500; SAR-440340 | ||
| Itepekimab (REGN-3500) is a monoclonal antibody of IL-33. Itepekimab reduces airway inflammation and related tissue damage in previous clinical studies. Itepekimab has potential application in asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis (AD). | ||
| M30453 | TRPC6-PAM-C20 | TRP Channel |
| TRPC6-PAM-C20 is a selective positive allosteric modulator (PAM) of TRPC6 channels. TRPC6-PAM-C20 is a potent enhancer of channel activation, enabling low basal concentrations of DAG to induce activation of the ion channel. TRPC6-PAM-C20 induces increases in intracellular Ca2+ concentrations ([Ca2+]i) in TRPC6-expressing HEK293 cells with an EC50 of 2.37 μM. TRPC6-PAM-C20 can be used as a valuable tool to selectively exaggerate TRPC6-dependent signals. | ||
| M49555 | JAK-IN-11 | JAK |
| JAK-IN-11 is a potent and selective JAK inhibitor extracted from patent WO2012122452A1, Compound II, has the potential for the skin disorders (such as cutaneous lupus) treatment. | ||
| M51755 | Z-D-His-OH | Amino Acid Derivatives |
| Z-D-His-OH is a histidine derivative. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
